Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

QT ECG

K-Number: K220795 · 2022-09-26

Decision Date2022-09-26
Product CodeDXH
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

QT ECG is a medical device manufactured by QT Medical, Inc.. It received FDA 510(k) clearance on 2022-09-26 under approval number K220795. The device is classified under product code DXH. It was reviewed by the CV advisory panel. Product code DXH falls under the category of Hematology, which includes devices for blood cell counting, coagulation testing, and hemoglobin analysis. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the QT ECG?

QT ECG is a medical device that received FDA 510(k) clearance on 2022-09-26. It is manufactured by QT Medical, Inc.. The 510(k) number is K220795.

When was QT ECG approved by the FDA?

QT ECG received FDA 510(k) clearance on 2022-09-26, under approval number K220795.

What company makes QT ECG?

QT ECG is manufactured by QT Medical, Inc..

What is the FDA product code for QT ECG?

The FDA product code for QT ECG is DXH. This falls under the Hematology category.

Other Devices by QT Medical, Inc.

Related Devices (Code: DXH)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.